AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Bumitama Agri today, you need to believe that its strong crude palm oil pricing, higher production volumes and generous dividends can more than compensate for rising ESG and regulatory headwinds. The latest results, with higher H1 2025 sales and earnings and a tripled interim dividend, reinforce the near term appeal of its cash returns and help explain why the share price is still up strongly year to date despite a recent pullback. At the same time, potential fines for plantations in designated forest zones and brokers shifting to Hold suggest that regulatory risk is now a key short term catalyst for sentiment, not just an asterisk in the footnotes. In other words, the story is no longer only about yields and operational efficiency, but about how the group manages compliance and credibility.
However, investors should be aware of how unresolved forest-zone issues could affect both cash flows and valuations. Despite retreating, Bumitama Agri's shares might still be trading above their fair value and there could be some more downside. Discover how much.Explore 8 other fair value estimates on Bumitama Agri - why the stock might be worth less than half the current price!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com